Benthic community metabolism in deep and shallow Arctic lakes during 13 years of whole–lake fertilization

Benthic primary production and oxygen consumption are important components of lake biogeochemical cycling. We performed whole–lake nutrient manipulations in Arctic Alaska to assess the controls of lake morphometry, nutrients, and light on benthic community metabolism. One deep, stratified lake (Lake E5) and one shallow, well–mixed lake (Lake E6) in the Alaskan Arctic were fertilized with low levels of nitrogen (56 mg N m−3 yr−1) and phosphorus (8 mg P m−3 yr−1) from 2001 to 2013. Benthic primary production was not stimulated by fertilization in either lake. In the deep lake, decreased water clarity is consistent with an increase in phytoplankton biomass during fertilization. Benthic GPP decreased by 7–47 mg C m−2 d−1 (not statistically significant) and benthic respiration increased from 87 ± 20 to 167 ± 9 (SE) mg C m−2 d−1. The areal hypolimnetic oxygen deficit increased by 15 mg O2 m−2 d−1 each year during the 13 yr of monitoring, apparently driven by lower (more negative) benthic NEP. In the shallow lake, phytoplankton concentration did not change with fertilization. As a result, the light environment did not change and benthic GPP did not decrease. Overall the data suggest that (1) benthic algae are not nutrient limited in either the deep or shallow lake, (2) lake morphometry modulated the overall nutrient impact on benthic metabolism by controlling the response of phytoplankton, and by extension, light and organic carbon supply to the benthos, (3) year–to–year variability in light attenuation explains considerable variability in benthic GPP between lakes and years, (4) correlations between both dissolved organic carbon concentrations and light attenuation coefficients (kd) between lakes suggests a regional control on light attenuation, and (5) the dissolved oxygen concentrations in the deep experimental lake are highly sensitive to nutrient enrichment.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/113758/1/lno10120.pd

Effect of continuous light on leaf wax isotope ratios in Betula nana and Eriophorum vaginatum: Implications for Arctic paleoclimate reconstructions

Author Posting. © The Author(s), 2018. This is the author's version of the work. It is posted here under a nonexclusive, irrevocable, paid-up, worldwide license granted to WHOI. It is made available for personal use, not for redistribution. The definitive version was published in Organic Geochemistry 125 (2018): 70-81, doi: 10.1016/j.orggeochem.2018.08.008.Reconstructions of climate using leaf wax D/H ratios (δDwax) require accounting for the apparent isotopic fractionation (εapp) between plant source water and waxes. There have been conflicting publications on whether plants in the Arctic growing under 24-hour continuous light, fractionate less than temperate and tropical plants. In this study, we examine the effect of diurnal light (DL) versus 24-hour continuous light (CL) on the isotopic composition of leaf n-alkanes and n-acids in greenhouse experiments using two common Arctic plants (Eriophorum vaginatum, or tussock cottongrass and Betula nana, or dwarf birch). For E. vaginatum, the δDwax values of various wax homologues were 5–11‰ more positive for CL plants relative to their DL counterparts, whereas for B. nana, CL waxes were 3–24‰ more negative, suggesting that daylight length is not a unifying control on leaf wax D/H ratios of Arctic plants. The δ13Cwax of B. nana was more negative for plants grown in continuous light compared to diurnal light, reflecting lower water-use efficiency, associated with prolonged stomatal opening in the CL treatment. We modeled the impact of increasing stomatal conductance and effective flow path lengths (mimicking variable leaf morphologies) on the isotopic composition of leaf waters (δDlw) and find that variations in leaf-water enrichment may explain the variable δDwax responses seen between E. vaginatum and B. nana. We suggest that between-species differences in the δDlw response to light, and differences in the utilization of stored carbohydrates, were important for governing δDwax. Our greenhouse results suggest that Arctic plant leaf waxes do not consistently display reduced εapp values as a result of 24-hour day light, providing additional support for field observations.We thank Fred Jackson and Chris Claussen of the Brown University Plant Environmental Center for assistance with growth chambers, Chelsea Parker for assistance in plant care, and Rafael Tarozo for laboratory assistance. We want to thank Trevor Porter and three anonymous reviewers for constructive comments to improve the manuscript. This work was funded by NSF Arctic Natural Sciences grant 1503846 to Yongsong Huang and James Russell and NSF-OPP grant 1603214 to Anne Giblin. We also acknowledge graduate support for Will Daniels from the Brown-MBL joint graduate program and the Institute at Brown for Environment and Society

Solution Structure of a CUE-Ubiquitin Complex Reveals a Conserved Mode of Ubiquitin Binding

AbstractMonoubiquitination serves as a regulatory signal in a variety of cellular processes. Monoubiquitin signals are transmitted by binding to a small but rapidly expanding class of ubiquitin binding motifs. Several of these motifs, including the CUE domain, also promote intramolecular monoubiquitination. The solution structure of a CUE domain of the yeast Cue2 protein in complex with ubiquitin reveals intermolecular interactions involving conserved hydrophobic surfaces, including the Leu8-Ile44-Val70 patch on ubiquitin. The contact surface extends beyond this patch and encompasses Lys48, a site of polyubiquitin chain formation. This suggests an occlusion mechanism for inhibiting polyubiquitin chain formation during monoubiquitin signaling. The CUE domain shares a similar overall architecture with the UBA domain, which also contains a conserved hydrophobic patch. Comparative modeling suggests that the UBA domain interacts analogously with ubiquitin. The structure of the CUE-ubiquitin complex may thus serve as a paradigm for ubiquitin recognition and signaling by ubiquitin binding proteins

Prolonged Drying Trend Coincident with the Demise of Norse Settlement in Southern Greenland

Declining temperature has been thought to explain the abandonment of Norse settlements, southern Greenland, in the early 15th century, although limited paleoclimate evidence is available from the inner settlement region itself. Here, we reconstruct the temperature and hydroclimate history from lake sediments at a site adjacent to a former Norse farm. We find no substantial temperature changes during the settlement period but rather that the region experienced a persistent drying trend, which peaked in the 16th century. Drier climate would have notably reduced grass production, which was essential for livestock overwintering, and this drying trend is concurrent with a Norse diet shift. We conclude that increasingly dry conditions played a more important role in undermining the viability of the Eastern Settlement than minor temperature changes

LEADER 3—Lipase and Amylase Activity in Subjects With Type 2 Diabetes: Baseline Data From Over 9000 Subjects in the LEADER Trial

Objectives: This report from the LEADER (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results) trial describes baseline lipase and amylase activity in type 2 diabetic subjects without acute pancreatitis symptoms before randomization to the glucagonlike peptide analog liraglutide or placebo. Methods: The LEADER is an international randomized placebo-controlled trial evaluating the cardiovascular safety of liraglutide in 9340 type 2 diabetic patients at high cardiovascular risk. Fasting lipase and amylase activity was assessed at baseline, before receiving liraglutide or placebo, using a commercial assay (Roche) with upper limit of normal values of 63 U/L for lipase and 100 U/L for amylase. Results: Either or both enzymes were above the upper limit of normal in 22.7% of subjects; 16.6% (n = 1540) had an elevated lipase level (including 1.2% >3-fold elevated), and 11.8% (n = 1094) had an elevated amylase level (including 0.2% >3-fold elevated). In multivariable regression models, severely reduced kidney function was associated with the largest effect on increasing activity of both. However, even among subjects with normal kidney function, 12.2% and 7.7% had elevated lipase and amylase levels. Conclusions: In this large study of type 2 diabetic patients, nearly 25% had elevated lipase or amylase levels without symptoms of acute pancreatitis. The clinician must take these data into account when evaluating abdominal symptoms in type 2 diabetic patients

LEADER 3: Lipase and amylase activity in subjects with type 2 diabetes

Objectives: This report from the LEADER (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results) trial describes baseline lipase and amylase activity in type 2 diabetic subjects without acute pancreatitis symptoms before randomization to the glucagonlike peptide analog liraglutide or placebo. Methods: The LEADER is an international randomized placebo-controlled trial evaluating the cardiovascular safety of liraglutide in 9340 type 2 diabetic patients at high cardiovascular risk. Fasting lipase and amylase activity was assessed at baseline, before receiving liraglutide or placebo, using a commercial assay (Roche) with upper limit of normal values of 63 U/L for lipase and 100 U/L for amylase. Results: Either or both enzymes were above the upper limit of normal in 22.7% of subjects; 16.6% (n = 1540) had an elevated lipase level (including 1.2% \u3e3-fold elevated), and 11.8% (n = 1094) had an elevated amylase level (including 0.2% \u3e3-fold elevated). In multivariable regression models, severely reduced kidney function was associated with the largest effect on increasing activity of both. However, even among subjects with normal kidney function, 12.2% and 7.7% had elevated lipase and amylase levels. Conclusions: In this large study of type 2 diabetic patients, nearly 25% had elevated lipase or amylase levels without symptoms of acute pancreatitis. The clinician must take these data into account when evaluating abdominal symptoms in type 2 diabetic patients

Design of the liraglutide effect and action in diabetes: evaluation of cardiovascular outcome results (LEADER) trial.

BACKGROUND: Diabetes is a multisystem disorder associated with a nearly twofold excess risk for a broad range of adverse cardiovascular outcomes including coronary heart disease, stroke, and cardiovascular death. Liraglutide is a human glucagon-like peptide receptor analog approved for use in patients with type 2 diabetes mellitus (T2DM). STUDY DESIGN: To formally assess the cardiovascular safety of liraglutide, the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial was commenced in 2010. LEADER is a phase 3B, multicenter, international, randomized, double-blind, placebo-controlled clinical trial with long-term follow-up. Patients with T2DM at high risk for cardiovascular disease (CVD) who were either drug naive or treated with oral antihyperglycemic agents or selected insulin regimens (human NPH, long-acting analog, or premixed) alone or in combination with oral antihyperglycemics were eligible for inclusion. Randomized patients are being followed for up to 5 years. The primary end point is the time from randomization to a composite outcome consisting of the first occurrence of cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke. CONCLUSIONS: LEADER commenced in September 2010, and enrollment concluded in April 2012. There were 9,340 patients enrolled at 410 sites in 32 countries. The mean age of patients was 64.3 ± 7.2 years, 64.3% were men, and mean body mass index was 32.5 ± 6.3 kg/m2. There were 7,592 (81.3%) patients with prior CVD and 1,748 (18.7%) who were high risk but without prior CVD. It is expected that LEADER will provide conclusive data regarding the cardiovascular safety of liraglutide relative to the current standard of usual care for a global population of patients with T2DM

Nipah Virus-associated Encephalitis Outbreak, Siliguri, India

Nipah virus, not previously detected in India, caused an outbreak of febrile encephalitis in West Bengal